Other headlines for [ELN]

• ELN 11/18/2008 02:08pm
  Elan Corp PLC CEO: Sees 20% market share as achievable over time for Tysarbri, expects to complete pipeline transaction by mid 2009 with Oncology or other drugs- Notes could continue cost cutting measures through more...
  
• ELN 11/10/2008 01:18pm
  Elan Corp PLC Signs agreement with Azur Pharma to Develop a Once-Daily Clozapine- Clozapine is currently marketed in immediate release presentations, including Azur's proprietary orally disintegrating tablet more...
  
• JNJ 11/1/2008 06:03pm
  Johnson & Johnson Inc Study suggests treatment with Paliperidone ER improves symptoms of schizoaffective disorder-Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) more...
  
• BIIB 10/29/2008 04:29pm
  Biogen Idec, Inc. Notified of case of PML in one MS patient taking Tsyabri - filing- the patient had gotten 14 doses of Tysabri before being diagnosed with the brain illness PML
  
• ELN 10/24/2008 09:58am
  Elan Corp PLC Caris & Company Raised ELN to Average from Sell (timing uncertain)- likely pre-open
  

Healthcare sector headlines

• GENZ Today 09:22am
  Genzyme Corp European Patent on cross-linked Gel Slurries has been revoked by EPO board of appeal- Announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation has been more...
  
• NABI Today 09:15am
  Nabi Biopharmaceuticals Increases patent portfolio with receipt of two patents for components of PentaStaph- European Patent Office issued Patent EP No. 0 925 073 that provides composition-of-matter protection in the EU more...
  
• HOLX Today 09:12am
  Hologic, Inc. Price Target lowered to $22 from $24 at Lazard, maintains buy rating
  
• CORT Today 09:00am
  Corcept Therapeutics Incorpora Names Caroline Loewy as new CFO- Ms. Loewy most recently served as CFO of Poniard Pharmaceuticals, a publicly traded biopharmaceutical company, where she was a key driver of that company's corporate more...
  
• LHCG Today 08:57am
  LHC Group Guides FY09 EPS $1.90-2.00 v $1.93e, R $450M-$470M v $436.2Me